Raksha Kanthavara Rao

Dr. Raksha Kanthavara Rao


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
RRRaksha Kanthavara Rao
Raksha Kanthavara Rao
MMMeghana Manjunath
Meghana Manjunath
RSR. Saiswaroop
R. Saiswaroop
DPDurga Prasad Patnana
Durga Prasad Patnana
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan

24 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
SRSaiswaroop Rajaratnam
Saiswaroop Rajaratnam
ASAkhil P. Soman
Akhil P. Soman
KPKanikaram Sai Phalguna
Kanikaram Sai Phalguna
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
MMMeghana Manjunath
Meghana Manjunath
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan
Amyotrophic lateral sclerosis (ALS) is a multi-systemic, incurable, amyloid disease affecting the motor neurons, resulting in the death of patients. The disease is either sporadic or familial with SOD1, C9orf72, FUS, and TDP-43 constituting the majority of familial ALS. Multi-omics studies on patients and model systems like mice and yeast have helped in understanding the association of various signaling and metabolic pathways with the disease. The yeast model system has played a pivotal role in elucidating the gene amyloid interactions. We carried out an integrated transcriptomic and metabolomic analysis of the TDP-43 expressing yeast model to elucidate deregulated pathways associated with the disease. The analysis shows the deregulation of the TCA cycle, single carbon metabolism, glutathione metabolism, and fatty acid metabolism. Transcriptomic analysis of GEO datasets of TDP-43 expressing motor neurons from mice models of ALS and ALS patients shows considerable overlap with experimental results. Furthermore, a yeast model was used to validate the obtained results using metabolite addition and gene knock-out experiments. Taken together, our result shows a potential role for the TCA cycle, cellular redox pathway, NAD metabolism, and fatty acid metabolism in disease. Supplementation of reduced glutathione, nicotinate, and the keto diet might help to manage the disease.

6 July 2022 in Genes
Verified
Journal Article
Open access
PDF file
MMMeghana Manjunath
Meghana Manjunath
SSSai Swaroop
Sai Swaroop
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
RRRaksha Kanthavara Rao
Raksha Kanthavara Rao
Raghunandan MahadevaRaghunandan Mahadeva
Raghunandan Mahadeva
BCBibha choudhary
Bibha choudhary
Transcriptomic profiling of several drugs in cancer cell lines has been utilised to obtain drug-specific signatures and guided combination therapy to combat drug resistance and toxicity. Global metabolomics reflects changes due to altered activity of enzymes, environmental factors, etc. Integrating transcriptomics and metabolomics can provide genotype-phenotype correlation, providing meaningful insights into alterations in gene expression and its outcome to understand differential metabolism and guide therapy. This study uses a multi-omics approach to understand the global gene expression and metabolite changes induced by Disarib, a novel Bcl2-specific inhibitor in the Ehrlich adenocarcinoma (EAC) breast cancer mouse model. RNAseq analysis was performed on EAC mouse tumours treated with Disarib and compared to the controls. The expression of 6 oncogenes and 101 tumour suppressor genes interacting with Bcl2 and Bak were modulated upon Disarib treatment. Cancer hallmark pathways like DNA repair, Cell cycle, angiogenesis, and mitochondrial metabolism were downregulated, and programmed cell death platelet-related pathways were upregulated. Global metabolomic profiling using LC-MS revealed that Oncometabolites like carnitine, oleic acid, glycine, and arginine were elevated in tumour mice compared to normal and were downregulated upon Disarib treatment. Integrated transcriptomic and metabolomic profiles identified arginine metabolism, histidine, and purine metabolism to be altered upon Disarib treatment. Pro-angiogenic metabolites, arginine, palmitic acid, oleic acid, and myristoleic acid were downregulated in Disarib-treated mice. We further validated the effect of Disarib on angiogenesis by qRT-PCR analysis of genes in the VEGF pathway. Disarib treatment led to the downregulation of pro-angiogenic markers. Furthermore, the chorioallantoic membrane assay displayed a reduction in the formation of the number of secondary blood vessels upon Disarib treatment. Disarib reduces tumours by reducing oncometabolite and activating apoptosis and downregulating angiogenesis.

28 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAfiya Raziya Chida
Afiya Raziya Chida
SRSamathmika Ravi
Samathmika Ravi
SJSuvratha Jayaprasad
Suvratha Jayaprasad
KPKiran Paul
Kiran Paul
JSJaysmita Saha
Jaysmita Saha
SSSubhashini Srinivasan
Subhashini Srinivasan
Malaria remains a major healthcare risk to growing economies like India and a chromosome-level reference genome of Anopheles stephensi is critical for successful vector management and an understanding of vector evolution. We report a chromosome-level assembly of an Indian strain from draft genomes of two strains using a homology-based iterative approach. The resulting assembly with an L50 of 9 had long enough scaffolds for building 90% of the three chromosomes using physical markers. The sequencing of individuals reveals a genetic diversity ten times higher than what is reported. Based on the developmental transcriptome and orthology of the 54 olfactory receptors (ORs) to those of other Anopheles species, we identify olfactory receptors with the potential for host recognition in the genus Anopheles . A comparative analysis of the genomes suggests limited inter-chromosomal gene flow and chromosomal arm switching with a potential role in adaptive radiation within the genus Anopheles .